Australia markets closed

CSL Limited (CMXHF)

OTC Markets OTCQX - OTC Markets OTCQX Delayed price. Currency in USD
Add to watchlist
200.000.00 (0.00%)
At close: 09:31AM EDT

CSL Limited

655 Elizabeth Street
Melbourne, VIC 3000
61 3 9389 1911

Full-time employees32,065

Key executives

NameTitlePayExercisedYear born
Dr. Paul F. McKenzie Ph.D.MD, CEO & Executive Director2.75MN/A1966
Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFIChief Financial Officer2.05MN/A1965
Mr. Mark DehringHead of Investor RelationsN/AN/AN/A
Mr. Gregory Boss B.S., BS(Hons), J.D.Executive VP of Legal & General Counsel1.1MN/A1961
Christina HickieSenior Manager of CommunicationsN/AN/AN/A
Ms. Roanne ParryChief Human Resources OfficerN/AN/AN/A
Dr. Karen EtchbergerExecutive Vice President of Quality & Business Services1.03MN/A1958
Ms. Jemimah BrennanHead of Communications - Asia PacificN/AN/AN/A
Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D.Senior Vice President of ResearchN/AN/A1962
Dr. William Mezzanotte M.D., M.P.H.Executive VP & Head of Research and Development1.46MN/A1959
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Corporate governance

CSL Limited’s ISS governance QualityScore as of 1 July 2024 is 2. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.